Health Care
In 2026-Q2, Humana Inc. achieved total revenue of $40.87B, up 26.2% YoY, and diluted EPS of $5.73, driven by strong Medicare Advantage enrollment growth despite benefit ratio headwinds from Star Ratings and medical claims trends.
Key risk: Regulatory and Medicare Star Ratings Headwinds
Humana faces ongoing regulatory exposure from Medicare Advantage benchmark funding changes, Inflation Reduction Act provisions, and Star Ratings adjustments, which directly constrain premium growth and underwriting profitability.
Other Managed Health Care companies